Allergan Files Suit Against Ackman, Valeant; May Hurt

HFA Padded
Mark Melin
Published on
Updated on

Allergan, Inc. (NYSE:AGN) just filed a lawsuit against Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) and Pershing Square that may have hit below the belt – or at least in a highly vulnerable spot. Allergan’s charges against Ackman and Valeant The complaint charges that William Ackman’s Pershing Square hedge fund and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) violated insider trading laws and failed to disclose material information in advance of a takeover. Ackman and Valeant both planed the purchase of Allergan stock and Ackman is documented to have purchased interest in this stock before this was public knowledge. There are key…

This content is exclusively for paying members of Hedge Fund Alpha

Log In

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!

HFA Padded

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.

Comments are closed.